You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-HLA antibodies,

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Medicare Anti-Aß mAb Coverage With Evidence Development Study

Recruiting
  • Mild Alzheimer's Disease
  • Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
  • Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
  • Baltimore, Maryland
    Centers for Medicare and Medicaid Services
Sep 21, 2023

Anti-HLA Immunization And Immunosuppressive Therapy Management

Active, not recruiting
  • Kidney Transplantation
  • +3 more
  • management of immunosuppressive therapy
  • Nancy, Lorraine, France
    Central HNF
Mar 24, 2022

Seroprevalence of Anti-SARS-CoV-2 Antibodies in Kidney

Completed
  • COVID-19 Pandemic
  • Transplantation, Kidney
  • No intervention
  • Ostrava, Czechia
    University Hospital Ostrava
Dec 6, 2022

Patient With Anti-GABAbr Antibodies Associated-encephalitis.

Completed
  • Autoimmune Encephalitis
  • Long-term outcome
  • Lyon, France
    Centre de référence des syndromes neurologiques paranéoplasiques
Feb 14, 2023

Hepatocellular Carcinoma Trial in Shanghai (Anti-PD-1/PD-L1, S-Adenosyl-Methionine)

Recruiting
  • Hepatocellular Carcinoma
  • Shanghai, China
    Zhongshan Hospital Fudan university
Jan 31, 2023

Kidney Transplant Rejection Trial in Los Angeles (Extended-release tacrolimus, Immediate-release tacrolimus)

Recruiting
  • Kidney Transplant Rejection
  • Extended-release tacrolimus
  • Immediate-release tacrolimus
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jan 18, 2022

Systemic Lupus Erythematosus, Pulmonary Arterial Hypertension Trial in Beijing (Rituximab)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Pulmonary Arterial Hypertension
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 13, 2023

Anti-NMDAR Encephalitis Trial in Paris (IA session, Rituximab)

Recruiting
  • Anti-NMDAR Encephalitis
  • Paris, France
    Hôpital Necker Enfants-Malades
Oct 31, 2022

COVID-19, SARS CoV 2 Infection Trial in Orléans (Collection of biological samples)

Not yet recruiting
  • COVID-19
  • SARS CoV 2 Infection
  • Collection of biological samples
  • Orléans, France
    Centre Hospitalier Régional d'Orléans, France
Jul 21, 2022

Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster

Terminated
  • Anti-SARS-CoV-2 Antibody Response
  • blood and saliva samples will be taken
  • Graz, Austria
    Medizinische Universität Graz, Klinische Abteilung für Rheumatol
Jan 9, 2023

Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite

Completed
  • Metastatic Colorectal Adenocarcinoma
  • regorafenib plus anti-PD-1 antibodies
  • Changsha, Hunan, China
    Hunan Cancer hospital
Jul 4, 2023

Periodontal Diseases, Rheumatoid Arthritis Trial in Cairo (Non surgical periodontal treatment)

Recruiting
  • Periodontal Diseases
  • Rheumatoid Arthritis
  • Non surgical periodontal treatment
  • Cairo, Egypt
    Faculty of oral and dental medicine, Misr international universi
Jan 23, 2023

Glanzmann Thrombasthenia Trial in France (Antibodies screening)

Active, not recruiting
  • Glanzmann Thrombasthenia
  • Antibodies screening
  • Bordeaux, France
  • +8 more
Jul 5, 2022

Alzheimer Trial (Lecanemab)

Not yet recruiting
  • Alzheimer Disease
  • (no location specified)
Jun 22, 2023

Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)

Recruiting
  • Lupus Erythematosus Disseminatus
  • +2 more
    • Montpellier, France
    • +1 more
    Sep 5, 2022

    A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies

    Recruiting
    • Immunocompromised Patients
    • Data collection
    • Paris, Ile De France, France
      Assistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
    Jul 5, 2022

    COVID-19 Trial in Petach Tikva (no intervantion)

    Active, not recruiting
    • COVID-19
    • no intervantion
    • Petach Tikva, Israel
      Schneider Children's Medical Center
    Sep 29, 2022

    Isolation of Human Recombinant Therapeutic Monoclonal

    Recruiting
    • Pseudomonas Aeruginosa
    • Multi-antibiotic Resistance
    • Isolation of anti-Pseudomonas antibodies from type B lymphocytes
    • Grenoble, France
      Chu Grenoble Alpes
    May 6, 2022

    Oral Care of Patients Treated With Anti-RANK-ligand Antibodies

    Recruiting
    • Giant Cell Tumors
      • Strasbourg, France
        Service de Médecine et Chirurgie Bucco-Dentaires - CHU de Strasb
      Sep 12, 2022

      Hypersensitivity, Immediate, Peri-operative Injury, Antibiotic Allergy Trial in Paris (IgG group, IgE group, IgG group + IgE

      Not yet recruiting
      • Hypersensitivity, Immediate
      • +3 more
      • IgG group
      • +2 more
      • Paris, France
        Hôpital Bichat claude Bernard
      Jun 10, 2022

      First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney

      Active, not recruiting
      • Kidney Diseases
      • +5 more
      • Booster dose of mRNA vaccine
      • Praha, Czechia
        Institute for Clinical and Experimental Medicine
      Aug 2, 2022

      Long COVID, Post-Acute Sequela of COVID-19, Post-Acute COVID-19 Trial in San Francisco (AER002, Placebo)

      Not yet recruiting
      • Long COVID
      • +2 more
      • San Francisco, California
        UCSF/Zuckerberg San Francisco General Hospital
      Jun 2, 2023

      Kidney Failure, Acute Trial in Marseille (Apheresis technics)

      Recruiting
      • Kidney Failure, Acute
      • Apheresis technics
      • Marseille, France
        Assisatance Publique Hôpitaux de Marseille
      Mar 22, 2022

      Clostridium Infection Trial in Paris (Collection of peripheral blood mononuclear cells)

      Completed
      • Clostridium Infection
      • Collection of peripheral blood mononuclear cells
      • Paris, France
        Maladies infectieuses et tropicales, Hôpital Pitié-Salpêtrière
      Oct 3, 2022

      Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b

      Recruiting
      • Hepatocellular Carcinoma
      • Shanghai, China
        Zhongshan Hospital, Fudan University
      Mar 28, 2022